Whole Exome Sequencing (WES) in Non-Small Cell Lung Carcinoma (NSCLC): Identification of Novel Biomarkers

被引：0
|
作者：
Singh, V. [1 ]
Katiyar, A. [2 ]
Malik, P. [3 ]
Mohan, A. [4 ]
Singh, H. [2 ]
Jain, D. [1 ]
机构：
[1] All India Inst Med Sci, Pathol, New Delhi, India
[2] All India Inst Med Sci, Indian Council Med Res, Div ISRM, Computat Genom Ctr, New Delhi, India
[3] All India Inst Med Sci, Med Oncol, New Delhi, India
[4] All India Inst Med Sci, Dept Pulm Crit Care & Sleep Med, New Delhi, India
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
NSCLC; Biomarkers; WES; Whole exome sequencing;
D O I：
10.1016/j.jtho.2019.08.1199
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.14-48
引用
收藏
页码：S574 / S574
页数：1
相关论文
共 50 条
  • [21] Exome sequencing identifies somatic mutations in novel driver genes in non-small cell lung cancer
    Zhang, Manman
    Zhang, Lele
    Li, Yan
    Sun, Feng
    Fang, Ya
    Zhang, Ruijia
    Wu, Jin
    Zhou, Guanbiao
    Song, Huaidong
    Xue, Liqiong
    Han, Bing
    Zheng, Cuixia
    AGING-US, 2020, 12 (13): : 13701 - 13715
  • [22] A SYSTEMATIC REVIEW AND CONSENSUS RECOMMENDATIONS ON THE USE OF BIOMARKERS IN THE TREATMENT OF NON-SMALL CELL LUNG CARCINOMA (NSCLC)
    Ellis, P. M.
    Blais, N.
    Soulieres, D.
    Ionescu, D. N.
    Liu, G.
    Melosky, B.
    Reiman, T.
    Shepherd, F. A.
    Tsao, M.
    Leighl, N. B.
    ANNALS OF ONCOLOGY, 2010, 21 : 131 - 131
  • [23] Prognostic and predictive biomarkers in non-small cell lung carcinoma
    Odintsov, Igor
    Sholl, Lynette m.
    PATHOLOGY, 2024, 56 (02) : 192 - 204
  • [24] MASS SPECTROMETRIC IDENTIFICATION OF NOVEL PROTEOMIC BIOMARKERS OF NON-SMALL CELL LUNG CANCER
    Streeper, R.
    Mussman, R.
    Campos, D.
    Diaz, A.
    Baek, S.
    Long, T.
    Izbicka, E.
    LUNG CANCER, 2009, 64 : S37 - S37
  • [25] IDENTIFICATION OF A NOVEL MICRORNA PANEL: POTENTIAL BIOMARKERS FOR NON-SMALL CELL LUNG CANCER
    Kan, C.
    Crovetto, N.
    Landreneau, R.
    Li, L.
    Soyer, H.
    Stark, M. S.
    Gunn, S.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2020, 68 (02) : 666 - 666
  • [26] Identification of potential inhibitors for drug-resistant EGFR mutations in non-small cell lung cancer using whole exome sequencing data
    Nagarajan, Nagasundaram
    Guda, Chittibabu
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [27] MONOTOTAL-MARKER FOR NON-SMALL CELL LUNG CARCINOMA (NSCLC)
    Prazakova, M.
    Topolcan, O.
    Svobodova, S.
    Vrzalova, J.
    Pecen, L.
    Krakorova, G.
    Treska, V.
    Spisakova, M.
    Holubec, L., Jr.
    Pesek, M.
    TUMOR BIOLOGY, 2010, 31 : S48 - S48
  • [28] microRNAs as a Tool for the Subtyping of Non-Small Cell Lung Carcinoma (NSCLC).
    Cabanas, M. L.
    Navarro, A.
    Marrades, R.
    Campayo, M.
    Vinolas, N.
    Diaz, T.
    Monzo, M.
    Ramirez, J.
    LABORATORY INVESTIGATION, 2011, 91 : 406A - 406A
  • [29] The Use of a Novel Immunohistochemical Triple Cocktail in the Subclassification of Non-Small Cell Lung Carcinoma (NSCLC)
    Kim, K. Hoo
    Chaudoir, C. S.
    Reid, M. D.
    Chaudhery, S. I.
    MODERN PATHOLOGY, 2014, 27 : 480A - 480A
  • [30] The Use of a Novel Immunohistochemical Triple Cocktail in the Subclassification of Non-Small Cell Lung Carcinoma (NSCLC)
    Kim, K. Hoo
    Chaudoir, C. S.
    Reid, M. D.
    Chaudhery, S. I.
    LABORATORY INVESTIGATION, 2014, 94 : 480A - 480A
12345